Semaglutide for Severe Obesity Post-Surgery

Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth

Recruiting Phase 3 Interventional Study
Pediatric Obesity Metabolic and Bariatric Surgery Semaglutide
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 18
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
150 (estimated)
Sponsor
Children's Hospital Los Angeles · Other
Who this trial is looking for

This trial is looking for young people aged 12 to 18 who have severe obesity and are undergoing weight loss surgery. Participants will take a medication called semaglutide or receive standard care for two years after surgery.

Are You a Good Fit for This Trial?
Must be taking Semaglutide
Rules you out Type 1 diabetes

You may be able to join if

  • I am between 12 and 18 years old
  • I have severe obesity
  • I am undergoing weight loss surgery
  • I have been taking semaglutide 2.4 mg weekly before surgery
  • I am willing to have blood collected before and after surgery
  • I have a consenting caregiver
  • I am in Tanner stage 3 or higher

You may not be able to join if

  • I have a previous diagnosis of type 1 diabetes
  • I take medications that affect weight
  • I have been diagnosed with certain syndromes affecting surgery
  • I have significant medical conditions requiring frequent hospitalization
  • I refuse to comply with eligibility criteria

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This is a Phase 3a, randomized, parallel-controlled trial designed to compare the early re-initiation of semaglutide, starting two weeks after sleeve gastrectomy, to standard care (no pharmacotherapy following surgery). The trial will involve 150 youth with severe obesity who have been on semaglutide 2.4 mg weekly for at least 3 months prior to surgery. Participants will be randomized to either (1…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ages 12 to 18 years * Tanner stage 3 or higher * severe obesity (defined as a BMI greater than 35 kg/m2 or BMI ≥140% of the 95th percentile) * currently undergoing primary surgical weight loss through the pediatric bariatric surgery pathway at Children's Hospital Los Angeles *…
Contacts

Alaina P Vidmar, MD

530-383-1732

avidmar@chla.usc.edu

CONTACT

Kamran Samakar, MD

Kamran.Samakar@med.usc.edu

CONTACT